Expert opinion on the Introduction of HPV Vaccines in EU Countries

Public health guidance

22 Jan 2008

This guidance report lays down the scientific basis for the potential introduction of human papillomavirus (HPV) vaccines in order to help European Union (EU) Member States to make policy choices. It highlights the issues to be considered and it provides a list of policy options for each of these issues.

Download

0801_GUI_Introduction_of_HPV_Vaccines_in_EU.pdf - EN - [PDF-526.45 KB]

080122_PR_HPV_Factsheet.pdf - EN - [PDF-63.01 KB]

Related content

Public health guidance for assessing and mitigating the risk of locally-acquired Aedes-borne viral diseases in the EU/EEA

1 Jul 2025 - This guidance provides key information on Aedes-borne viruses, the principles of the laboratory diagnosis of these viruses and the epidemiology of Aedes-borne viral disease in Europe.

Public health advice for EuroPride 2025

13 Jun 2025 - Ahead of EuroPride 2025 (June 14–22) in Lisbon, Portugal, the European Centre for Disease Prevention and Control (ECDC), the World Health Organization Regional Office for Europe (WHO/Europe), and Portugal’s Direção-Geral da Saúde (DGS) have together issued health advice for people attending the events.

Joint public health advice for travellers attending the 2024 Summer Olympic and Paralympic Games

18 Jul 2024 - Helping fans stay safer this summer: Public health advice developed for spectators of the Summer Olympic and Paralympic Games.

Load More

Infectious disease topics

Spotlight

Publications and data

Spotlight

Training and tools

Spotlight

About ECDC

Spotlight

Expert opinion on the Introduction of HPV Vaccines in EU Countries

Download

Related content

Public health guidance for assessing and mitigating the risk of locally-acquired Aedes-borne viral diseases in the EU/EEA

Public health advice for EuroPride 2025

Joint public health advice for travellers attending the 2024 Summer Olympic and Paralympic Games

Follow us: